- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01476540
Deep Brain Stimulation for the Treatment of Refractory Anorexia Nervosa
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Anorexia nervosa is a chronic, and debilitating psychiatric disorder associated with the highest mortality rate of any psychiatric condition. Despite advances in neuroimaging, genetics, pharmacology and psychosocial interventions in the last half century, little progress have been made in altering the natural history of the condition or its outcomes. It has further become increasingly accepted that the thoughts and behaviors at the root of AN derive from dysfunctional neuroanatomic circuits, whose activity and deviations can be detected with sophisticated neuroimaging techniques. Much progress has also been made in mapping the psychology of the illness to underlying neuroanatomic and neurophysiologic processes that drive and maintain these behaviors, even in the face of severe starvation and impending death. Dysfunctional reward processing, compulsive hyperactivity, chronic anxiety and depression, all suggest that AN shares much in common with other conditions, such as OCD, for which surgical therapy has been tried, and met with success.
Deep Brain Stimulation is a neurosurgical tool that has been widely used for over twenty years. Most of the experience with DBS comes from the movement disorder literature where significant success has been had with the management of disabling Parkinson's disease (PD) and dystonia. The most experience so far has been in Parkinson's disease where well over 50,000 patients globally have received the operation. DBS is believed to work by using small amounts of electricity to disrupt the activity of brain structures that produce troublesome symptoms. DBS has also been used in psychiatric patients, both as part of treatment and research, in cases of Obsessive-Compulsive Disorder (OCD), and research, in cases of Depression. Current research suggests that there are similarities between Anorexia Nervosa and conditions such as OCD and depression. Given that DBS has shown promise in the treatment of those conditions, this trial was designed to see if it could be an effective therapy for Anorexia Nervosa as well.
This study would be the first exploration of a surgical therapy for refractory AN. The rationale stems from clear and robust evidence pointing at a dysfunctional cortical-subcortical loop driving abnormal behavior, with several important nodes in the loop being particularly important, and recurring, players. The subgenual cingulate plays a role in affective decision making, reward processing, as well as subsequent anxiety and dysphoric mood.
There are currently no brain based, targeted therapies for AN. The scientific significance of this study will be:
i) The first clinical trial exploring deep brain stimulation in an eating disorder population
ii) The first demonstration of the influence of deep brain stimulation on dysfunctional reward processing with co-morbid anxiety/dysphoria
iii) The first 'brain-based' treatment for any eating disorder
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Ontario
-
Toronto, Ontario, Canadá, M5T2S8
- Toronto Western Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Female or Male patients between age 20-60
- Diagnosis of Anorexia Nervosa, restricting or binge-purging subtype as defined by the Diagnostic and Statistical Manual (DSM-IVR)
Chronicity and/or Treatment Resistance as demonstrated by some or all of:
- A pattern of three year's duration of relentless unresponsiveness to repeated voluntary hospitalizations, characterized by failure to complete treatment of immediate weight relapse following treatment;
- pattern of increasing medical instability accompanied by refusal to participate in/lack of responsiveness to intensive expert treatment and increasing medical acuity, lasting at least two years and involving at least two episodes of involuntary feeding;
- A pattern of chronic stable AN lasting at least 10 years
- Able to comply with all testing, follow-ups and study appointments and protocols
Exclusion Criteria:
- Any past or current evidence of psychosis
- Active neurologic disease such as epilepsy
- Alcohol or substance dependence or abuse in the last 6 months, excluding caffeine and nicotine
- Any contraindication to Magnetic Resonance Imaging (MRI) or Positron Emission Tomography (PET) scanning
- Likely to relocate or move during the study's one year duration
- BMI less than 13
- Presence of cardiac arrhythmias, or other cardiac, respiratory, renal or endocrine conditions as a result of AN or not, that will result in significant risk from a surgical procedure.
- Pregnancy
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Deep Brain Stimulation
|
Deep Brain Stimulation (DBS) is a neurosurgical procedure involving the implantation of deep brain electrodes, connected via a subcutaneous extension wire, to an implantable pulse generator (IPG, or 'battery') that is implanted below the collarbone.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Eating Disorder Related Preoccupations and Rituals
Periodo de tiempo: Change from baseline in Eating Disorder Related Preoccupations and Rituals scores at 3 months, 6 months and 12 months
|
Eating Disorder Related Preoccupations and Rituals scores
|
Change from baseline in Eating Disorder Related Preoccupations and Rituals scores at 3 months, 6 months and 12 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Depression
Periodo de tiempo: Change from baseline in depression scores at 3 months, 6 months and 12 months
|
Hamilton Depression Rating Scale (HAMD), Beck Depression Inventory (BDI)
|
Change from baseline in depression scores at 3 months, 6 months and 12 months
|
|
Anxiety
Periodo de tiempo: Change from baseline in anxiety scores at 3 months, 6 months and 12 months
|
Beck Anxiety Inventory (BAI)
|
Change from baseline in anxiety scores at 3 months, 6 months and 12 months
|
|
Quality of Life questionnaire score through change from baseline compared to post-implant visit
Periodo de tiempo: Change from baseline in Quality of Life scores at 3 months, 6 months and 12 months
|
Health Survey Short Form (SF36), Quality of Life Scale
|
Change from baseline in Quality of Life scores at 3 months, 6 months and 12 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Andres M Lozano, MD, PhD, University Health Network, Toronto
- Investigador principal: Blake Woodside, MD, Toronto General Hospital
Publicaciones y enlaces útiles
Publicaciones Generales
- Lipsman N, Lam E, Volpini M, Sutandar K, Twose R, Giacobbe P, Sodums DJ, Smith GS, Woodside DB, Lozano AM. Deep brain stimulation of the subcallosal cingulate for treatment-refractory anorexia nervosa: 1 year follow-up of an open-label trial. Lancet Psychiatry. 2017 Apr;4(4):285-294. doi: 10.1016/S2215-0366(17)30076-7. Epub 2017 Feb 24.
- Lipsman N, Woodside DB, Giacobbe P, Hamani C, Carter JC, Norwood SJ, Sutandar K, Staab R, Elias G, Lyman CH, Smith GS, Lozano AM. Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: a phase 1 pilot trial. Lancet. 2013 Apr 20;381(9875):1361-1370. doi: 10.1016/S0140-6736(12)62188-6. Epub 2013 Mar 7.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 10-0991-A
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Deep Brain Stimulation
-
University of MinnesotaReclutamiento
-
Applied Science & Performance InstituteAún no reclutandoFatiga | La privación del sueño | Cognitivo | Estado de ánimo y rendimiento cognitivo | Función ejecutiva (cognición)Estados Unidos
-
NHS Greater Glasgow and ClydeAún no reclutandoLesión Cerebral Traumática (TBI); Conmoción cerebral, contacto inicial
-
BrainswayTerminadoTrastorno depresivo mayorEstados Unidos, India, Israel
-
Washington University School of MedicineReclutamientoLesiones de la médula espinal (LME)Estados Unidos
-
Beijing Pins Medical Co., LtdBeijing Tiantan HospitalDesconocidoEpilepsia refractariaPorcelana
-
Medical College of WisconsinTerminadoTrastornos neurocognitivosEstados Unidos
-
Sheba Medical CenterElMindA Ltd; BrainswayDesconocido
-
BeerYaakov Mental Health CenterWeizmann Institute of ScienceDesconocido
-
Changping LaboratoryReclutamientoAfasia | Apoplejía IsquémicaPorcelana